your market intelligence analyst
Search Results
348 results
Your search is now limited to «Roche» expert search.
PMLiVE 05/29/2020 08:20
Roche and Gilead Sciences are joining forcers to fight COVID-19 with a 450-patient trial that will combine two drugs already being tested against coronavirus as monotherapies.
More from PMLiVE:
Business Wire 05/29/2020 08:00
Our initial neurology program with Roche continues to make great progress and we hope to assist Roche in bringing multiple meaningful therapies to patients in areas of neurological disease with major unmet needs through both our initial and this new program.
More from Business Wire:
GlobeNewswire 05/29/2020 06:03
Rozlytrek has also received approvals by health authorities in Australia, Canada, Hong Kong, Israel and South Korea.1 About Roche in lung cancer Lung cancer is a major area of focus and investment for Roche, and we are committed to developing new approaches, medicines and tests that can help people with this deadly disease.
More from GlobeNewswire:
Roche has announced the commencement of phase III clinical study of Actemra/RoActemra plus remdesivir in hospitalised patients with severe Covid-19 pneumonia.
More from Pharmaceutical Business Review: 05/28/2020 18:28
An appellate state court in New Jersey has ruled that a class action lawsuit by hundreds of homeowners who allege the value of their homes has dropped because of groundwater contaminated by Swiss drugmaker Hoffmann-La Roche Inc and three more defendants can proceed.
More from
World Pharma News 05/28/2020 04:00
Roche is committed to sharing data from the COVACTA study as soon as possible this summer.
More from World Pharma News:
Pharmafile 05/27/2020 06:09
NHS patients with treatment-naïve extensive-stage small-cell lung cancer (ES-SCLC) in England and Wales will soon have access to a new treatment option as NICE reveals it has authorised Roche’s Tecentriq (atezolizumab) in this indication. The therapy ­has been recommended in combination with carboplatin and etoposide chemotherapy.
More from Pharmafile:
Hoffmann-La Roche (EU) 05/25/2020 09:00
No summary found
More from Hoffmann-La Roche (EU): 05/25/2020 00:01
Roche announced that it has acquired Stratos Genomics, an early-stage sequencing technology company to advance the development of Roche’s nanopore sequencer.
More from
Xconomy 05/22/2020 10:40
As the nation started to reopen this week following two months of closed businesses and stay-at-home orders, public health officials and economists cautioned that society won’t truly return to anything resembling a pre-pandemic normal without a COVID-19 vaccine.
More from Xconomy:
BioNewsFeeds 05/22/2020 08:15
For a comprehensive support app developed for multiple sclerosis (MS) patients, RxMx and Roche have won the Patient Engagement Innovation Award from Medtech Breakthrough. The fourth annual awards program recognized top health and medical technology products and companies. Healthcare company RxMx and pharmaceutical company Roche collaborated to produce a streamlined and simplified MS patient support program that […]
More from BioNewsFeeds:
Financial Post (Canada) 05/21/2020 14:07
Roche expects production to reach the high double-digit millions by June and pass the 100 million monthly threshold later this year.
More from Financial Post (Canada):
Science Media Centre 05/21/2020 12:13
There have been reports that the UK government plans to by COVID-19 antibody tests from the pharmaceutical company Roche. …
More from Science Media Centre:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications